Get started
Author

Elisheva Pokroy‐Shapira

Observed names: E Pokroy-Shapira, E. Pokroy-Shapira, Elisheva Pokroy Shapira, Elisheva Pokroy-Shapira, Pokroy-Shapira, Elisheva
ORCID: 0000-0002-4050-6642
Observed ORCID: 0000-0002-4050-6642
OpenAlex ID: A5048752246
Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study
2014 · Elisheva Pokroy-Shapira, Ilana Gelernter, et al. · Clinical Rheumatology · 54
Epstein–Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti‐ DNA
2013 · Ittai Fattal, Noam Shental, et al. · Immunology · 46
Serum Soluble Triggering Receptor on Myeloid Cells-1 (sTREM-1) is Elevated in Systemic Lupus Erythematosus but does not Distinguish Between Lupus Alone and Concurrent Infection
2013 · Yair Molad, Elisheva Pokroy-Shapira, et al. · Inflammation · 32
CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding
2013 · Yair Molad, Elisheva Pokroy-Shapira, et al. · Innate Immunity · 23
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare
2022 · Iftach Sagy, Yarden Cohen, et al. · Lupus · 21
Soluble triggering receptor expressed on myeloid cells‐1 is a biomarker of anti‐ CCP ‐positive, early rheumatoid arthritis
2015 · Yair Molad, Shachaf Ofer‐Shiber, et al. · European Journal of Clinical Investigation · 20
Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome
2019 · Yonatan Edel, Vitaly Kliminski, et al. · Arthritis Research & Therapy · 16
PDF
A Cross-sectional Survey on the Preference of Patients with Rheumatoid Arthritis for Route of Administration of Disease-Modifying Anti-Rheumatic Drugs: Oral Target-Specific Versus Parenteral Biologic.
2020 · Yonatan Edel, Iftach Sagy, et al. · PubMed · 15
Systemic lupus erythematosus exacerbation following cessation of belimumab treatment
2015 · V Furer, D Zisman, et al. · Scandinavian Journal of Rheumatology · 14
Capnocytophagabacteraemia following rituximab treatment
2012 · Elisheva Pokroy-Shapira, Shachaf Shiber, et al. · BMJ Case Reports · 10
PDF
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations
2023 · Fadi Kharouf, Tali Eviatar, et al. · Frontiers in Immunology · 6
Safety of biologic therapy in kidney and liver transplant recipients with systemic inflammatory diseases: a real-world study from Israel
2025 · Victoria Furer, Omer Kersh, et al. · Rheumatology · 3
Guanine polynucleotides are self‐antigens for human natural autoantibodies and are significantly reduced in the human genome
2015 · Ittai Fattal, Noam Shental, et al. · Immunology · 3
PDF
Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study
2022 · Yair Molad, Mohamad Egbaria, et al. · Clinical and Experimental Rheumatology · 2
Coexistence of Mycosis Fungoides and Photosensitive or Autoimmune Diseases. The Therapeutic Challenge: A retrospective Case Series from a Tertiary Referral Center.
2025 · Meital Oren-Shabtai, Assi Levi, et al. · PubMed · 1
The Effect of Different Ethnic Origins in Israel on the Clinical Manifestations and Outcomes of Systemic Lupus Erythematous.
2023 · Yehudit Nahum, Iftach Sagy, et al. · PubMed · 1
Pos1254 Risk Factors for Severe Covid-19 Infection Among Patients With Autoimmune Inflammatory Rheumatic Diseases (aird) and the Impact of Vaccinations - an Israeli, Multi-center Experience
2022 · F. Kharouf, T. Eviatar, et al. · Annals of the Rheumatic Diseases
PDF
Pos1217 the Pattern of Covid 19 Pandemic Among Patients With Autoimmune Inflammatory Rheumatic Diseases (aiird)
2021 · F. Kharouf, T. Eviatar, et al. · Annals of the Rheumatic Diseases
PDF
Comorbidity Accrual and Mortality Rate for Patients with Giant-Cell Arteritis and Polymyalgia Rheumatica are Similar Regardless of Glucocorticoid Cumulative Dose: A Longitudinal, Retrospective Study
2020 · Elisheva Pokroy-Shapira, Ariela Dortort-Lazar, et al.
PDF
S3D:5 Plasma soluble triggering receptor expressed on myeloid cells-1 is elevated in patients with thrombotic primary antiphospholipid syndrome
2018 · Y Molad, Y Edel, et al. · Lupus Science & Medicine
PDF
[IgG4-RELATED DISEASE].
2017 · Elisheva Pokroy-Shapira, Yair Molad · PubMed
Authors’ reply
2017 · V Furer, D Zisman, et al. · Scandinavian Journal of Rheumatology
Works count: 24
Citation count: 267
H-index: 10
I10-index: 10
Year
Topic
Type